We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$94B
AUM Growth
+$5.35B
(+6%)
Cap. Flow
-$10.2B
Cap. Flow
% of AUM
-10.87%
Top 10 Holdings %
Top 10 Hldgs %
22.25%
Holding
2,551
New
400
Increased
743
Reduced
692
Closed
262
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinnacle West Capital
PNW
|
+$455M |
| 2 |
PNC Financial Services
PNC
|
+$306M |
| 3 |
Otis Worldwide
OTIS
|
+$234M |
| 4 |
Colgate-Palmolive
CL
|
+$212M |
| 5 |
NorthWestern Energy
NWE
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$545M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$293M |
| 3 |
CSX Corp
CSX
|
+$210M |
| 4 |
Baxter International
BAX
|
+$171M |
| 5 |
Dollar Tree
DLTR
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.36% |
| 2 | Healthcare | 14.2% |
| 3 | Financials | 13.3% |
| 4 | Industrials | 9.5% |
| 5 | Consumer Discretionary | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Seres Therapeutics
MCRB
$48.4M
| $68K | ﹤0.01% |
+414
| New | +$65.8K |
|
1402
National Healthcare
NHC
$3.37B
| $68K | ﹤0.01% |
1,010
+819
| +429% | +$56.7K |
|
1403
Progress Software
PRGS
$1.76B
| $68K | ﹤0.01% |
1,413
+241
| +21% | +$12K |
|
|
RUTH
1404
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $68K | ﹤0.01% |
+3,425
| New | +$65.6K |
|
|
SIVB
1405
DELISTED
SVB Financial Group
SIVB
| $68K | ﹤0.01% |
+101
| New | +$71.2K |
|
|
UBA
1406
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $68K | ﹤0.01% |
3,219
+1,869
| +138% | +$37.5K |
|
1407
argenx
ARGX
$54.1B
| $67K | ﹤0.01% |
194
-185
| -49% | -$56.3K |
|
1408
National Beverage
FIZZ
$3.01B
| $67K | ﹤0.01% |
1,486
+160
| +12% | +$8.71K |
|
|
FOLD
1409
DELISTED
Amicus Therapeutics
FOLD
| $67K | ﹤0.01% |
5,856
-112,559
| -95% | -$1.25M |
|
1410
OneMain Financial
OMF
$7.47B
| $67K | ﹤0.01% |
1,353
+217
| +19% | +$11.5K |
|
1411
Oppenheimer Holdings
OPY
$1.2B
| $67K | ﹤0.01% |
1,448
+141
| +11% | +$6.95K |
|
1412
OraSure Technologies
OSUR
$279M
| $67K | ﹤0.01% |
7,737
+3,260
| +73% | +$32.2K |
|
1413
STAG Industrial
STAG
$7.19B
| $67K | ﹤0.01% |
1,403
+684
| +95% | +$29.8K |
|
|
ACBI
1414
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $67K | ﹤0.01% |
2,344
+476
| +25% | +$13.5K |
|
1415
Bridgewater Bancshares
BWB
$603M
| $66K | ﹤0.01% |
3,738
+531
| +17% | +$9.49K |
|
1416
Corcept Therapeutics
CORT
$12B
| $66K | ﹤0.01% |
3,369
-61,418
| -95% | -$1.25M |
|
1417
Digi International
DGII
$3.1B
| $66K | ﹤0.01% |
2,687
+582
| +28% | +$13.3K |
|
1418
LCI Industries
LCII
$2.65B
| $66K | ﹤0.01% |
429
| – | – |
|
1419
Littelfuse
LFUS
$11.6B
| $66K | ﹤0.01% |
211
+60
| +40% | +$18.1K |
|
1420
Regenxbio
RGNX
$708M
| $66K | ﹤0.01% |
2,040
-1,799
| -47% | -$61.3K |
|
1421
RE/MAX Holdings
RMAX
$242M
| $66K | ﹤0.01% |
2,165
+935
| +76% | +$28.5K |
|
|
SEMR
1422
DELISTED
Semrush
SEMR
| $66K | ﹤0.01% |
+3,203
| New | +$71.4K |
|
|
UMH
1423
UMH Properties
UMH
$1.36B
| $66K | ﹤0.01% |
2,436
+362
| +17% | +$8.72K |
|
1424
Usana Health Sciences
USNA
$286M
| $66K | ﹤0.01% |
658
+97
| +17% | +$9.68K |
|
|
NTUS
1425
DELISTED
Natus Medical Inc
NTUS
| $66K | ﹤0.01% |
2,802
+281
| +11% | +$6.93K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Lazard Asset Management held 2,551 positions worth $94B, up 6% from $88.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $10.2B in Q4 2021, closing 262 positions and reducing 692 holdings. Its most notable exit was Innospec, an estimated $21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Wells Fargo 7.5% Non Cumv Perp Conv worth $922K.
- Lazard Asset Management's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 61,920 shares worth $922K.
- Lazard Asset Management added most to Pinnacle West Capital in Q4 2021, an estimated $455M increase.
- Lazard Asset Management's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $545M.
- Lazard Asset Management fully exited Innospec in Q4 2021, selling an estimated $21M.
- Lazard Asset Management's ten largest holdings make up 22% of its $94B portfolio in Q4 2021.
- Lazard Asset Management opened 400 new positions and closed 262 in Q4 2021.
- Lazard Asset Management's portfolio value rose 6% quarter-over-quarter to $94B.
Based on Lazard Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.